Bellin S I, Landas S K, Johnson A K
Department of Psychology, University of Iowa, Iowa City 52242.
Brain Res. 1988 Jul 19;456(1):9-16. doi: 10.1016/0006-8993(88)90340-x.
Ablation of the periventricular tissue of the anteroventral third ventricle (AV3V) or injection of the chemical neurotoxin, 6-hydroxydopamine (6-OHDA), into the structures along the ventral lamina terminalis will produce deficits in drinking and pressor responses to exogenous angiotensin II (ANG II). Centrally-applied 6-OHDA has been shown to result in widespread depletions of both adrenergic (i.e. both noradrenaline and adrenaline-containing) and dopaminergic neurons. Questions arise, therefore, as to whether a dopaminergic or adrenergic depletion is critical and the locus where reductions must occur. The present experiment was designed to investigate the specificity of the effects of 6-OHDA administration into lamina terminalis-associated structures on ANG II-induced drinking and pressor responses. The nature of the depletion was manipulated with desmethylimipramine (DMI), a drug which blocks the uptake of 6-OHDA into adrenergic but not dopaminergic nerve terminals and thereby spares adrenergic elements. The experimental results indicate that 6-OHDA administration into structures of the ventral lamina terminalis produced ANG II response deficits and marked reductions in catecholamine histofluorescence in the regions of the injection sites. In contrast, pretreatment with DMI protected against the 6-OHDA-produced functional deficits and minimized the effects on histofluorescence. These findings are consistent with the interpretation that adrenergic but not dopaminergic neurons must be present in the structures of the ventral lamina terminalis in order to elicit normal angiotensin-induced drinking and pressor responses.
损毁腹侧第三脑室前腹侧(AV3V)的室周组织,或将化学神经毒素6-羟基多巴胺(6-OHDA)注入终板腹侧结构,会导致对外源性血管紧张素II(ANG II)的饮水和升压反应出现缺陷。已证明中枢应用6-OHDA会导致肾上腺素能(即含去甲肾上腺素和肾上腺素的)和多巴胺能神经元广泛耗竭。因此,出现了这样的问题:多巴胺能或肾上腺素能的耗竭是否至关重要,以及必须发生减少的部位在哪里。本实验旨在研究将6-OHDA注入终板相关结构对ANG II诱导的饮水和升压反应影响的特异性。用去甲丙咪嗪(DMI)来控制耗竭的性质,DMI是一种能阻断6-OHDA进入肾上腺素能神经末梢但不能进入多巴胺能神经末梢的药物,从而使肾上腺素能成分得以保留。实验结果表明,将6-OHDA注入终板腹侧结构会产生ANG II反应缺陷,并使注射部位区域的儿茶酚胺组织荧光显著降低。相比之下,用DMI预处理可防止6-OHDA产生的功能缺陷,并使对组织荧光的影响最小化。这些发现与以下解释一致:为了引发正常的血管紧张素诱导的饮水和升压反应,终板腹侧结构中必须存在肾上腺素能神经元而非多巴胺能神经元。